Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes

We’re working to meet the needs of health care practitioners and their patients

Our in-depth knowledge of non-opioid pain management, coupled with our passion for delivering improved patient care, drives our commitment to providing solutions that address unmet medical needs and improve clinical results.

Pacira Core Values

We are a team of dedicated and highly talented professionals focused on driving improved patient outcomes with opioid-reducing strategies. We are an organization built on high ethical standards, an unwavering commitment to patients, and transparent communications. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society.

Patient safety and welfare are our top priority at all times.

Our people are our greatest asset.

We are passionate about what we do.

Our thoughts are shared generously.

Building trust is essential.

Teamwork is the cornerstone of our business success.

Dedicated Leadership

Our management team has unparalleled experience in the hospital and ambulatory surgical center marketplace and a track record of successfully commercializing products. This experience helps us to ensure that Pacira products, pipeline programs, and partnerships in the marketplace are consistently of the highest quality. As a public company (NASDAQ: PCRX), we hold our shareholders in the same high regard as we do the physicians and patients we serve.

Photo of David Stack

David Stack

Chief Executive Officer and Chairman

Mr. Stack has served as our Chief Executive Officer and as a director since November 2007, and as President from November 2007 to October 2015. In June 2013, Mr. Stack was appointed as the Chairman of our board of directors. Mr. Stack was Managing Director of MPM Capital, a private equity firm, from 2005 through March 2017 and has been a Managing Partner of Stack Pharmaceuticals, Inc., a commercialization, marketing, and strategy firm, since 1998. From 2001 to 2004, he was President and Chief Executive Officer of The Medicines Company (Nasdaq: MDCO). Previously, Mr. Stack was President and General Manager at Innovex, Inc. He was Vice President, Business Development/Marketing at Immunomedics from 1993 until 1995. Prior to that, he was with Roche Laboratories in positions of increasing responsibility from 1981 until 1993, including Therapeutic World Leader in Infectious Disease and Director, Business Development and Planning, Infectious Disease, Oncology, and Virology. He currently serves as a member of the board of directors of Prognos AI, Chiasma, Inc. (Nasdaq: CHMA) and Amarin Corporation plc (Nasdaq: AMRN). He was a member of the boards of directors of Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) from 2006 to 2010 and BioClinica, Inc. (Nasdaq: BIOC) from 1999 to 2010. Mr. Stack holds a B.S. in pharmacy from Albany College of Pharmacy and a B.S. in Biology from Siena College.

Photo of Max Reinhardt

Max Reinhardt

President, Rest of World

Max Reinhardt joined Pacira in June 2019 and serves as President, Rest of World. In this capacity Mr. Reinhardt oversees global commercialization efforts for the Pacira portfolio, as well as the company’s payer and employer relations activities and key customer partnerships. Mr. Reinhardt has twenty-five years of medical device experience and has held positions of increasing responsibility in sales, marketing and general management. Most recently he served as Vice President, Marketing at DePuy Synthes, where he led the negotiations and launch of the Pacira alliance to bring EXPAREL® to orthopedic customers nationwide. Prior to this role, Mr. Reinhardt served in several capacities at Johnson & Johnson including Director of Sales and Marketing for DePuy Spine in 2002, where he led the UK spine business before relocating to the US as Vice President of US Sales for DePuy Spine in 2006. In 2011 he was named Vice President, Worldwide Marketing, a position in which he played a key role in the acquisition and integration of Synthes Spine. In 2012 he was named Worldwide President, DePuy Synthes Spine, and led the spine business through the first two years of integration. Mr. Reinhardt was also responsible for the DePuy Synthes Joint Reconstruction, Mitek Sports Medicine, Early Intervention and the Power Tools divisions between 2015 and 2016. Prior to his time at Johnson & Johnson, Mr. Reinhardt served in sales leadership roles at both Olympus KeyMed and STERIS Corporation in the UK.

Mr. Reinhardt earned his Higher National Diploma at Sparsholt College of Agriculture in the UK and his Master of Science degree in marketing from the University of Hull, England.

Photo of Kristen Williams, JD

Kristen Williams, JD

Chief Administrative Officer and Secretary

Kristen Williams worked with the company as a legal consultant before joining as Corporate Counsel in December 2011. Since then, she has been promoted to Vice President, General Counsel in 2013 and to Chief Administrative Officer, General Counsel and Secretary in 2014. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc from June 2004 until its merger with Genzyme Corporation in 2007. From September 1999 to June 2004, she practiced corporate law at Paul Hastings LLP in New York, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry.

Ms. Williams earned a Bachelor of Science Degree in Business Administration from Bucknell University and a J.D. Degree from the University of Denver, College of Law in Denver, CO.

photo of Roy Winston

Roy Winston, MD

Chief Medical Officer

Roy Winston joined Pacira in 2017 and serves as Chief Medical Officer. Dr. Winston will oversee research and development and all customer facing medical operations in addition to medical strategy. Prior to being named Chief Medical Officer, Dr. Winston served as Chief Clinical Officer. He practiced anesthesiology and critical care medicine for over twenty-five years, and prior to joining Pacira full time, was chair of Anesthesiology at Palm Beach Children’s Hospital and St. Mary’s Medical Center. Dr. Winston has been on the faculty of The University of California at Irvine, Emory University and Florida State University and is a board-certified anesthesiologist. Dr. Winston served on The Georgia Composite State Board of Medical Examiners as Vice President and President Elect and worked with the legislature to create and modify healthcare policy. He is the founder of LaserAway, a national aesthetic dermatology group, and served as its chief executive officer from January 2005 until March 2007. Dr. Winston has served as CEO and president of LaserAway Medical Corp., the management group of LaserAway, since January 2005. Dr. Winston is an honorably discharged veteran of the U.S. Navy and received his Bachelor of Arts from the University of Pennsylvania and his medical degree from the Icahn School of Medicine at Mount Sinai. He completed his residency training in anesthesiology at The University of Florida.

Photo of Charles Laranjeira

Charles Laranjeira

Chief Technical Officer

Charles Laranjeira joined Pacira in 2017, bringing over 30 years of knowledge and experience in manufacturing, international operations, and technical operations. Since December 2018, Charles has served as Chief Technical Officer at Pacira, overseeing the company’s research and development efforts as well as manufacturing, quality, and supply chain functions. Additionally, Charles manages strategy and execution for the Pacira supply network of both internal capabilities and contract partners globally. He previously served as Senior Vice President, Technical Operations from May 2017 to December 2018.

Charles has a long track record of success in managing multiple products throughout all phases of the product lifecycle. His previous leadership positions include serving as Vice President of Supply Operations for Epirus Biopharmaceuticals, a biopharmaceutical company from September 2015 until May 2016. Prior to this role, Charles served as Senior Vice President, Technical Operations for Cubist Pharmaceuticals through its acquisition of 3 companies and launch of 3 new products from June 2011 to April 2015. Charles has extensive global experience, having led site operations for Bristol-Myers Squibb in the US, Australia, Spain, and Puerto Rico; as well as managing regional responsibilities as Vice President, Drug Product Manufacturing, Latin America, Asia Pacific and Japan.

He earned his Bachelor of Science in Industrial Administration from the New Jersey Institute of Technology and has spent the entirety of his career in pharmaceutical operations. Charles is based out of the Pacira Science Center Campus in San Diego, CA, which in addition to providing internal R&D and commercial manufacturing capabilities, serves as the company’s headquarters for technical operations globally.

Photo of Charles A. Reinhart III

Charles A. Reinhart III

Chief Financial Officer

In 2016, Charles A. Reinhart III joined Pacira as Chief Financial Officer, responsible for overseeing all financial and capital market activities at Pacira, including accounting, financial reporting, financial planning and analysis, and investor relations.

Prior to joining Pacira, Mr. Reinhart served as Chief Financial Officer of Covis Pharmaceuticals, Inc. From September 2011 to August 2014, he served as Executive Vice President and Chief Financial Officer of Archimedes Pharma Ltd. Mr. Reinhart also served as Senior Vice President and Chief Financial Officer of PharmAthene, Inc., a biodefense company engaged in the development of next generation medical countermeasures against biological and chemical threats, from 2009 to 2011. He has also held senior financial roles at Millennium Pharmaceuticals, Inc., Cephalon, Inc. and several early-stage life sciences companies. He also served as a director of Osiris Therapeutics, Inc. (Nasdaq: OSIR) from September 2018 until it was acquired in April 2019. Mr. Reinhart has successfully built and managed finance organizations within rapidly growing companies, responsible for accounting and financial reporting, financial planning and analysis, tax, treasury, risk management and procurement. He has worked closely with commercial teams to evaluate sales operations, monitor product pricing and implement contracting strategies. In addition, he has significant experience in investor relations, corporate development and capital raising. He has been integrally involved in equity and debt financing transactions, as well as the evaluation, acquisition and integration of multiple products and companies.

Mr. Reinhart earned his Bachelor of Science degree from Lehigh University and his MBA from the Wharton School of the University of Pennsylvania. He is also a CPA.

Photo of Dennis Mcloughlin

Dennis McLoughlin

Chief Customer Officer

Dennis McLoughlin serves as Chief Customer Officer at Pacira. Mr. McLoughlin joined Pacira in 2014 as part of the sales leadership team, overseeing several components of the business while fulfilling multiple roles including Chief Commercial Officer, Senior Vice President and Executive Director, Alliance Management. From December 2013 to January 2017, Mr. McLoughlin served as an Area Sales Director. With more than 20 years of pharmaceutical industry expertise, Mr. McLoughlin has extensive background in sales, marketing, managed markets, and strategic commercial operations.

Prior to joining Pacira, he was the President and a Principal of Remedy Group, a company with expertise in all phases of commercial operations, business development and corporate alliances for the pharmaceutical, life sciences and healthcare industries. Mr. McLoughlin has held various management positions in sales, national accounts, training, product marketing, and business development for GlaxoSmithKline and Organon Pharmaceuticals (now Merck). He earned his Bachelor of Science in Marketing from St. Joseph’s University in Philadelphia, Pennsylvania.

Jonathan Slonin

Jonathan Slonin, MD

Chief Clinical Officer

Dr. Jonathan Slonin joined Pacira in 2020 and currently serves as Chief Clinical Officer. In this role, Dr. Slonin directs the company’s customer-facing medical operations, including Medical Affairs and Strategic Accounts. He brings over 15 years of experience to Pacira as a board-certified anesthesiologist who has held numerous clinical and leadership positions with TeamHealth and Envision Healthcare including Regional Medical Director for the Southeast with TeamHealth and Chairman of Anesthesiology for the Cleveland Clinic Martin Medical System. Dr. Slonin received his Bachelor of Science in Biomedical Engineering and his MD degree from the University of Miami. He completed his anesthesiology residency at University of Miami/Jackson Memorial Hospital where he served as chief resident. Dr. Slonin received his MBA degree from George Washington University.